The dramatic result from the first patient in the Vertex trial, if reproduced, might come to be seen as the first clear demonstration that differentiation of stem cells into islet-like structures containing glucose-responsive insulin-secreting cells can reverse diabetes in humans. Here, INS is linked to diabetes mellitus.